Adagene Inc. (ADAG)
NASDAQ: ADAG · Real-Time Price · USD
1.860
+0.044 (2.42%)
Dec 31, 2025, 2:54 PM EST - Market open
Adagene Market Cap
Adagene has a market cap or net worth of $87.66 million as of December 31, 2025. Its market cap has decreased by -6.15% in one year.
Market Cap
87.66M
Enterprise Value
32.63M
1-Year Change
-6.15%
Ranking
Category
Stock Price
$1.86
Market Cap Chart
Since the IPO on February 9, 2021, Adagene's market cap has decreased from $804.22M to $87.66M, a decrease of -89.10%. That is a compound annual growth rate of -36.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 85.59M | -2.85% |
| Dec 31, 2024 | 88.10M | 4.06% |
| Dec 29, 2023 | 84.66M | 47.15% |
| Dec 30, 2022 | 57.54M | -83.64% |
| Dec 31, 2021 | 351.59M | -56.28% |
| Feb 9, 2021 | 804.22M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 965.00B |
| Johnson & Johnson | 500.24B |
| AbbVie | 406.46B |
| UnitedHealth Group | 300.58B |
| AstraZeneca | 286.29B |
| Novartis AG | 267.64B |
| Merck & Co. | 265.03B |
| Novo Nordisk | 232.28B |